PLAY PODCASTS
The BioMedWire Podcast

The BioMedWire Podcast

[email protected]

116 episodesEN

Show overview

The BioMedWire Podcast has been publishing since 2020, and across the 6 years since has built a catalogue of 116 episodes. That works out to roughly 25 hours of audio in total. Releases follow a monthly cadence.

Episodes typically run under ten minutes — most land between 7 min and 16 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language News show.

The show is actively publishing — the most recent episode landed 3 weeks ago, with 8 episodes already out so far this year. The busiest year was 2020, with 48 episodes published. Published by [email protected].

Episodes
116
Running
2020–2026 · 6y
Median length
8 min
Cadence
Monthly

From the publisher

Fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation

Latest Episodes

View all 116 episodes

When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

Apr 24, 202618 min

When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech [Video Edition]

Apr 24, 202618 min

BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc. (NASDAQ: SNGX)

Mar 19, 202628 min

BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc. (NASDAQ: SNGX) [Video Edition]

Mar 19, 202628 min

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

Feb 23, 202618 min

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A [Video Edition]

Feb 23, 202618 min

The BioMedWire Podcast featuring Earth Science Tech Inc. (OTC: ETST) CEO Giorgio R. Saumat

Feb 17, 202614 min

The BioMedWire Podcast featuring Earth Science Tech Inc. (OTC: ETST) CEO Giorgio R. Saumat [Video Edition]

Feb 17, 202614 min

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now [Video Edition]

Dec 8, 202519 min

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

Dec 8, 202519 min

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

Oct 31, 202513 min

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology [Video Edition]

Oct 31, 202513 min

Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market [Video Edition]

Oct 27, 202516 min

Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market

Oct 27, 202516 min

BioMedWire Podcast Featuring Return of Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc. (OTCQB: OTLC) [Video Edition]

Oct 22, 202510 min

BioMedWire Podcast Featuring Return of Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc. (OTCQB: OTLC)

Oct 22, 202510 min

The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc. (OTCQB: OTLC)

Sep 22, 202512 min

The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc. (OTCQB: OTLC) [Video Edition]

Sep 22, 202512 min

NetworkNewsAudio Announces Audio Press Release (APR) on Innovation in Cancer, Rare Disease Treatment Space

Sep 19, 202514 min

NetworkNewsAudio Announces Audio Press Release (APR) on Innovation in Cancer, Rare Disease Treatment Space [Video Edition]

Sep 19, 202514 min